Early Chest Tube Removal for Lung Surgery
(PROTECTR Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the safety and feasibility of removing a chest tube just three hours after lung surgery performed with small incisions and a camera (VATS). The research compares this early removal approach to the usual practice of keeping the chest tube in longer, aiming to make recovery easier and faster for patients. Suitable participants have planned lung surgery through VATS for removing part of their lung and do not have severe lung function issues. As an unphased trial, this study offers patients the opportunity to contribute to innovative recovery methods that could enhance post-surgical care.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this protocol is safe for early chest tube removal?
Studies have shown that removing the chest tube soon after lung surgery is safe for many patients. Research indicates that removing the chest tube within hours of surgery does not cause harm, even with some fluid drainage. One study found it safe for patients undergoing video-assisted thoracoscopic surgery (VATS). Another study confirmed that early removal after lung tissue removal is both possible and safe. Overall, evidence supports that early chest tube removal is well-tolerated and doesn't increase the risk of complications for those meeting specific criteria.12345
Why are researchers excited about this trial?
Researchers are excited about early chest tube removal for lung surgery because it could significantly improve patient comfort and recovery time. Unlike the standard post-operative care, which involves keeping the chest tube in place for extended periods, this new approach removes the tube just three hours after surgery. This method has the potential to reduce pain, lower the risk of infection, and allow patients to return to normal activities sooner. Overall, it represents a shift towards more patient-friendly recovery protocols in lung surgery.
What evidence suggests that early chest tube removal is effective for lung surgery?
This trial will compare early chest tube removal with standard post-operative care. Research has shown that removing chest tubes soon after lung surgery can be safe and beneficial. Studies found that patients who had their chest tubes removed within 6 hours after surgery experienced fewer complications and reduced hospital stays. Another study discovered that same-day chest tube removal often resulted in just a one-day hospital stay. A combined analysis of several studies confirmed that early removal is safe and feasible, even for patients with significant fluid drainage. Overall, these findings suggest that early chest tube removal can enhance recovery after lung surgery.12467
Who Is on the Research Team?
Rahul Nayak, MD MSc
Principal Investigator
Western University
Are You a Good Fit for This Trial?
This trial is for patients who have undergone a minimally invasive lung surgery called VATS. It's testing if it's safe and possible to remove the chest tube on the same day of surgery, which could enhance recovery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Video Assisted Thoracic Surgery (VATS) with early chest tube removal at 3 hours post-operation
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of complications and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Early Chest Tube Removal
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lawson Health Research Institute
Lead Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor
London Health Sciences Centre OR Lawson Research Institute of St. Joseph's
Lead Sponsor
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
Lead Sponsor